Isemid

RSS

Torasemide

Authorised
This medicine is authorised for use in the European Union.

Overview

Isemid is a veterinary medicine used to treat signs related to congestive heart failure in dogs. Congestive heart failure is a condition when the heart cannot pump enough blood around the body. This can lead to exercise intolerance (inability to carry out physical activity), difficulty breathing and fluid retention. Isemid contains the active substance torasemide.

This EPAR was last updated on 07/02/2019

Authorisation details

Product details
Name
Isemid
Agency product number
EMEA/V/C/004345
Active substance
Torasemide
International non-proprietary name (INN) or common name
Torasemide
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) codes
QC03CA04
Publication details
Marketing-authorisation holder
CEVA Santé Animale
Revision
0
Date of issue of marketing authorisation valid throughout the European Union
09/01/2019
Contact address

10 avenue de La Ballastière
33500 Libourne
France

Product information

09/01/2019 Isemid - EMEA/V/C/004345 -

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.

 

Product information documents contain:

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

  • High-ceiling diuretics

  • Sulfonamides, plain

Therapeutic indication

For treatment of clinical signs related to congestive heart failure in dogs, including pulmonary oedema.

Assessment history

How useful was this page?

Add your rating